...
首页> 外文期刊>The Journal of communicable diseases >Relevance of Anti-BmR1 IgG4 Antibodies in Children from an Area Endemic for Brugia malayi Infection in Kerala, India
【24h】

Relevance of Anti-BmR1 IgG4 Antibodies in Children from an Area Endemic for Brugia malayi Infection in Kerala, India

机译:印度喀拉拉邦马来亚布鲁吉氏菌感染地方性地区儿童中抗BmR1 IgG4抗体的相关性

获取原文
获取原文并翻译 | 示例
           

摘要

Brugian filariasis prevalent mostly in South-East Asian countries including India contributes to a small but significant proportion of the socioeconomic burden due to lymphatic filariasis. Along with bancrof tian filariasis, brugian filariasis has been targeted for elimination globally. The lack of a reliable daytime diagnostic test has been seen as an important barrier to the successful implementation and monitoring of elimination programmes in brugia endemic areas. We evaluated an anti-BmRI-IgG4 antibody test namely, 'Brugia Rapid' in a large study meant to understand the clinical and pathological manifestations of brugian filariasis in children. We found the test superior to traditional night blood screening for microfilaraemia. Although an antibody detection test, we found it to be a reliable indicator of brugian infection. Among the 100 children studied extensively, 94% of the microfilaraemics, 86% of those showing filarial dance sign indicating presence of, live adult worms and 78% having abnormal lymphatics on lymphoscmtigraphy were IgG4 positive. Coupled with its advantages like ease of use any time of the day, high sensitivity and specificity, this test may be the ideal tool to assist programme managers in their efforts to eliminate lymphatic filariasis where brugian infections are found.
机译:布鲁日丝虫病多发于包括印度在内的东南亚国家,对淋巴丝虫病造成的社会经济负担贡献很小,但比例却很大。与班氏丝虫病一起,布鲁氏丝虫病已成为全球消灭丝虫病的目标。缺乏可靠的白天诊断测试已被视为在布鲁吉亚流行地区成功实施和监测消除计划的重要障碍。我们在一项大型研究中评估了一项抗BmRI-IgG4抗体测试,即“ Brugia Rapid”,旨在了解儿童布鲁氏丝虫病的临床和病理表现。我们发现该测试优于传统的夜间血液筛查微丝蛋白血症。尽管进行了抗体检测测试,但我们发现它是比利时感染的可靠指标。在接受广泛研究的100名儿童中,94%的微丝虫病,86%的显示丝状舞蹈迹象表明存在活体蠕虫的人和78%的淋巴描记法上的淋巴管异常的患者均为IgG4阳性。结合其优点,例如一天中任何时候的易用性,高灵敏度和特异性,该测试可能是协助计划管理者消除发现有布鲁氏菌感染的淋巴丝虫病的理想工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号